According to the current analysis of Reports and Data, the global Dystrophin Market was valued at 1.30 Billion in 2020 and is expected to reach USD 28.20 Billion by year 2028, at a CAGR of 47.00% percent. The growth of the dystrophin market is more in countries such as U.S, Austria, Czech Republic, Denmark, Germany, Hungary, Israel, Italy, Norway, Portugal, Slovakia, South Korea, and the United Kingdom; where key muscular dystrophy drugs are available in the market.

The market is characterized by the entry of a large number of players that includes emerging companies, as well as healthcare giants. The primary factor, for the focus of market players, is the unaddressed demand for treatment of muscular dystrophy diseases for a long time. There are over 35 companies engaged in clinical trials for the launch of novel therapeutics for the treatment of DMD. However, owing to stringent regulation across the globe for drug approval, very few drug candidates have received approval by medicine regulatory bodies such as the US Food and Drug Administration (FDA), and European Commission.

North America is expected to have a high demand on account of the product launches in the U.S. In 2017, North America dominated the dystrophin market in 2017, with a market share of 52.6; followed by Europe. The North America dystrophin market is estimated to be worth USD 45.6 billion by 2025. Factors such as high incidence of muscular dystrophy in the region, accelerated FDA approval of drug in the region, favorable funding scenario for research & development in field of DMD, high healthcare expenditure potential among the North American population, availability of medical reimbursement in the region are among key factors supporting the growth of dystrophin market in North America.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/download-free-sample/1063

Further key findings from the report suggest

  • Exon Skipping accounted for 45.3% of the overall industry in 2017 and will witness high growth owing to anticipated adoption across the globe after regulatory approval in Europe and other parts of the world. However, low awareness about therapeutics in developing nations is expected to hamper its growth over the forecast period.
  • Emerging approaches for muscular dystrophy therapies is expected to witness significant rise at a CAGR of ~90% from 2016 to 2025 in light of favorable inclination of the industry as well as healthcare professionals towards the development of new therapies.
  • Asia Pacific market was valued at USD 14.1 million in 2017 and is expected to reflect significant growth during the forecast period owing it to anticipated drug launches in the region. Favorable scenario for research and development funds and the presence of various emerging players in the region is likely to promote market growth over the forecast period. As of 2017, there is a lack of well-established effective muscular dystrophy therapy in the region, which is a significant factor for the low market share of the region.

Key Players covered in this report are:

PTC Therapeutics, Sarepta Therapeutics, BioMarin Pharmaceutical Inc, Wave Life Sciences, Bristol-Myers Squibb and Catabasis Pharmaceuticals among others.

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1063

Product Outlook (Revenue, USD Million, 2018 – 2028)

    • Exondys51
    • Translarna
    • Emflaza
    • Others

Approach Outlook (Revenue, USD Million, 2018 – 2028)

    • Exon Skipping
    • Anti-Inflammatory Therapy
    • Stop Codon Read-Through
    • Others Approaches

Geographic Segment Covered in the Report:

The Dystrophin report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

  • North America (USA and Canada)
  • Europe (UK, Germany, France and the rest of Europe)
  • Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
  • Latin America (Brazil, Mexico, and the rest of Latin America)
  • Middle East and Africa (GCC and rest of the Middle East and Africa)

Major Points covered in this report are as below:

• The Dystrophin industry development trends and marketing channels are analyzed. The feasibility of new investment projects are assessed and overall research conclusions offered.

• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

• Development policies and plans, manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue and gross margins.

• The Dystrophin Market report provides key statistics on the market status of the Dystrophin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1063

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report and our team will ensure you get the report tailored according to your needs.

Get Explore Latest Research Report by Reports and Data:

Depth Filtration Market @ https://www.biospace.com/article/depth-filtration-market-to-reach-usd-3-78-billion-by-2028-with-cagr-of-9-3-percent-says-reports-and-data/

Hollow Fiber Filtration Market @ https://www.biospace.com/article/hollow-fiber-filtration-market-size-to-reach-usd-881-53-million-in-2028-says-reports-and-data/

Microcarrier Market @ https://www.biospace.com/article/microcarrier-market-size-to-reach-usd-2-9-billion-by-2028-says-reports-and-data/

Anesthesia Machine Market @ https://www.biospace.com/article/revenue-growth-of-the-global-market-for-anesthesia-machines-is-being-driven-by-the-increasing-number-of-surgical-procedures-reports-and-data/

Polymeric Adsorbents Market @ https://www.biospace.com/article/polymer-adsorbents-market-is-in-boom-due-to-widely-used-in-the-pharmaceutical-and-food-and-beverage-industries-reports-and-data/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com